Project Abstract

Abstract
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and changes in bowel habits. The gut microbiota plays a crucial role in the pathogenesis of IBS, and emerging research suggests that probiotics supplementation may offer a promising therapeutic approach. This study aims to investigate the impact of probiotics supplementation on gut microbiota composition in individuals with IBS. Chapter One provides an introduction to the study, outlining the background, problem statement, objectives, limitations, scope, significance, structure of the research, and definition of terms. Chapter Two presents a comprehensive literature review, exploring existing research on probiotics, gut microbiota, and IBS. Chapter Three details the research methodology, including study design, participant recruitment, probiotics intervention, data collection methods, gut microbiota analysis techniques, statistical analysis, ethical considerations, and potential limitations. Chapter Four presents the findings of the study, discussing the effects of probiotics supplementation on gut microbiota composition in individuals with IBS. The results and implications of the study are analyzed and discussed in Chapter Four, highlighting the potential benefits of probiotics supplementation in managing IBS symptoms through modulating gut microbiota. Finally, Chapter Five provides a conclusion and summary of the research, emphasizing the significance of the findings and potential avenues for future research in this field. Overall, this research contributes to the growing body of evidence supporting the use of probiotics as a therapeutic intervention for individuals with IBS, offering insights into the mechanisms by which probiotics may influence gut microbiota composition and alleviate symptoms associated with this challenging condition.

Project Overview